Recent News for DXR - Daxor Corporation

Date Title
Aug 6 Daxor Corporation Announces the Acquisition of the BVA-100® Blood Volume Analyzer by a Leading Academic Health Center in the Pacific Northwest
Jul 29 Microcaps top midday movers
Jul 29 Pieris Pharmaceuticals and Pluristem Therapeutics among healthcare gainers; Lexicon Pharmaceuticals leads the losers
Jun 18 Daxor Corporation Announces New Research Initiative with Leading Hospital in the Southeast and the BVA-100® Blood Volume Diagnostic Test
May 31 Daxor Corporation to Present at the LD Micro 9th Annual Invitational on June 4th, 2019
May 30 Daxor up 15% on new BVA-100 deal
May 30 MiMedx Group and BioCryst Pharmaceuticals among healthcare gainers; Amicus Therapeutics and ReWalk Robotics among losers
May 30 Daxor Corporation Announces New Partnership with Leading Hospital in North Carolina to Integrate the BVA-100® Blood Volume Analyzer Diagnostic Test as Part of Standard Clinical Practice
May 27 Our Take On Daxor Corporation's (NYSEMKT:DXR) CEO Salary
May 6 SBGI, AMG, GIII and ZNH among notable midday movers
May 6 ImmunoGen and Athenex among healthcare gainers; AAC Holdings and PetMed Express among losers
Mar 21 Daxor Corporation Addresses and Corrects Erroneous Seeking Alpha Healthcare News Editor Article of March 20, 2019
Mar 20 Daxor down 11% after corporate presentation
Mar 15 Daxor Corporation to Present at the 31st Annual Roth Conference on March 19, 2019
Mar 4 Daxor Corporation Announces Rise in Kit Sales and Files Form N-CSR For 2018
Feb 22 Daxor's BVA-100 demonstrates ease of use in critically ill patients
Feb 22 New Research Further Demonstrates Clinical Utility and Improved Ease of Use with Daxor Corporation’s Blood Volume Analyzer (BVA-100®) in Critical Care
Back to the Main DXR Page...